Saliva Collection Devices Market Size, Share, Growth, and Industry Analysis, By Type (OraSure Technologies,Neogen Corporation,Isohelix,Diametra,AboGen, Inc,Quest Diagnostics,Spectrum Solutions,Oasis Diagnostics,Abbott Laboratories (Alere)), By Application (Pharma and Biotech Companies,Forensics,Dentistry,Diagnostic and Pathology Laboratories,Research Institutes), Regional Insights and Forecast to 2035

Saliva Collection Devices Market Overview

The global Saliva Collection Devices Market is forecast to expand from USD 1914.77 million in 2026 to USD 2029.09 million in 2027, and is expected to reach USD 3225.51 million by 2035, growing at a CAGR of 5.97% over the forecast period.

The saliva collection devices market has gained significant importance with the increasing adoption of non-invasive diagnostic methods. More than 60% of infectious disease tests are now incorporating saliva as a viable sample type due to its 97% accuracy compared with blood-based assays. Over 55 million DNA tests globally in 2023 utilized saliva kits, making it one of the most widely used biological sampling methods. More than 450 diagnostic assays in circulation currently use saliva collection tubes and swabs. With over 1.2 billion diagnostic tests conducted annually worldwide, saliva-based systems are emerging as a critical technology in healthcare markets.

The USA dominates the saliva collection devices market, with nearly 42% of total global consumption of saliva-based kits recorded in 2023. Over 110 million saliva samples were collected for diagnostic, pharmaceutical, and forensic purposes within the country during 2023. The U.S. Food and Drug Administration has cleared more than 120 saliva-based diagnostic kits, highlighting a strong regulatory landscape. In addition, more than 1,500 clinical laboratories across the USA currently employ saliva-based testing in areas such as oncology, infectious diseases, and pharmacogenomics. With a healthcare expenditure crossing $4.5 trillion in 2022, saliva testing devices continue to gain wider adoption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Over 65% of adoption is driven by non-invasive diagnostics gaining preference among patients.
• Major Market Restraint: Around 48% of laboratories cite high storage sensitivity as a restraint in using saliva devices.
• Emerging Trends: Nearly 52% of new diagnostic startups are focusing on saliva-based platforms by 2025.
• Regional Leadership: North America accounts for 41% of global saliva collection device demand in 2023.
• Competitive Landscape:Top 5 manufacturers collectively hold around 62% of the global saliva collection devices market share.
• Market Segmentation: Pharma and biotech companies utilize nearly 38% of saliva collection kits worldwide.
• Recent Development: Over 29% of new patents filed in 2024 were related to saliva-based device innovations.

Saliva Collection Devices Market Latest Trends

The saliva collection devices market is experiencing strong momentum with the rise of genetic testing and home-based diagnostics. More than 85 million at-home DNA and ancestry kits sold globally in 2023 relied heavily on saliva as the primary sample source. The trend toward personalized medicine has accelerated saliva device adoption, as more than 33% of pharmacogenomics studies in 2023 utilized saliva for genotyping. Furthermore, the use of saliva testing in infectious disease diagnostics is increasing, with over 90 approved tests targeting viral pathogens like influenza and COVID-19 using saliva swabs and vials.

The industry is also witnessing integration of digital health platforms. In 2024, over 25% of saliva device manufacturers introduced app-based connectivity for tracking, shipping, and results integration. In addition, forensic applications have grown, with saliva accounting for nearly 70% of DNA evidence samples processed in criminal cases across the U.S. and Europe in 2023. The adoption in dentistry has also risen, as nearly 12 million saliva-based periodontal diagnostics were carried out in 2023. With more than 400 clinical trials incorporating saliva devices, their role in future medical diagnostics, forensic science, and life sciences research is becoming increasingly critical for precision-driven healthcare solutions.

Saliva Collection Devices Market Dynamics

DRIVER

" Rising demand for pharmaceuticals."

The demand for pharmaceuticals is fueling saliva collection device adoption, with 39% of clinical trial specimen collection in 2023 conducted using saliva samples. More than 2,500 ongoing clinical studies worldwide incorporate saliva-based biomarker analysis, demonstrating its broad relevance. Compared to invasive venipuncture, saliva devices reduce sampling time by nearly 50% and improve patient compliance by 40%. As the global burden of chronic diseases grows—affecting over 1.9 billion individuals—pharmaceutical companies increasingly use saliva samples for drug metabolism and genetic testing. These advantages are establishing saliva as a preferred option for large-scale pharmacological studies.

RESTRAINT

 Demand for refurbished equipment.

Despite widespread use, around 47% of low-income markets rely on refurbished or low-cost alternatives, reducing the penetration of advanced saliva collection devices. In addition, saliva’s biological instability presents challenges: more than 30% of samples degrade under poor storage conditions if not stabilized within 12 hours. Laboratories in rural regions often lack access to the cold-chain storage infrastructure required, which affects reliability. Moreover, over 18% of researchers surveyed in 2024 cited sample contamination as a limitation. These factors collectively restrict the uniform adoption of high-quality devices, slowing penetration in emerging markets.

OPPORTUNIT

 "Growth in personalized medicines."

Personalized medicine is creating unprecedented opportunities, with nearly 43% of genetic testing laboratories incorporating saliva as a sample type by 2023. More than 70 million direct-to-consumer genomics tests rely on saliva kits, and this number is projected to expand further with growing consumer interest. Pharmacogenomic testing, which helps identify drug responses, has used saliva in more than 1,200 clinical settings across Europe and Asia. The expansion of precision oncology, with 19% of oncology biomarker studies using saliva samples, strengthens opportunities for device manufacturers. The demand for individualized treatment strategies ensures a sustained growth trajectory for saliva collection devices.

CHALLENGE

" Rising costs and expenditures."

One of the pressing challenges in the saliva collection devices market is cost. More than 35% of small laboratories cite affordability issues with advanced saliva stabilizing kits, which can cost up to three times more than basic swabs. Additionally, regulatory approval processes are becoming increasingly stringent, with the U.S. FDA issuing 24 new compliance guidelines in 2023 alone for sample collection devices. These compliance costs increase time-to-market, affecting manufacturers. Furthermore, 29% of startups in 2024 highlighted difficulties scaling due to rising raw material prices for plastics and reagents. Addressing cost concerns remains vital to ensuring equitable global adoption.

Saliva Collection Devices Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

• OraSure Technologies: OraSure Technologies held nearly 19% market share in 2023. Its saliva devices are widely used in infectious disease testing, with over 80 FDA-cleared products. The company reported over 25 million kits distributed annually, primarily for HIV and COVID-19 testing.
• Neogen Corporation : Neogen devices are used in food safety and diagnostics, with 14 million saliva kits sold in 2023 for veterinary and forensic purposes. The firm accounts for approximately 8% of the saliva device market, with distribution in over 100 countries.
• Isohelix: Isohelix specializes in DNA saliva kits, with over 20 million devices distributed in 2023 for genomics research. Their devices maintain DNA integrity for 5 years, making them essential in biobanking. The firm contributes nearly 7% of global market share.
• Diametra: Diametra focuses on immunodiagnostic applications. Their saliva kits are used in endocrinology, where more than 5 million cortisol tests annually rely on Diametra kits. They hold a market share of around 6% with increasing adoption in Europe.
• AboGen, Inc: AboGen is notable for consumer genomics. More than 12 million ancestry tests were facilitated using AboGen kits in 2023. They hold 5% of the global saliva devices market share, with strong demand in North America and Asia.
• Quest Diagnostics: Quest Diagnostics operates as both a diagnostic lab and saliva kit provider. In 2023, the company processed over 40 million saliva samples for genetic testing and disease screening, accounting for 11% of market share.
• Spectrum Solutions: Spectrum Solutions is a leading innovator, holding nearly 9% of market share in 2023. Their saliva stabilizing technology was used in more than 60 million COVID-19 diagnostic tests worldwide.
• Oasis Diagnostics: Oasis Diagnostics contributes around 4% of the market share. Their saliva devices are widely utilized in cancer biomarker testing, with over 2 million oncology samples processed in 2023.
• Abbott Laboratories (Alere): Abbott accounts for nearly 12% of the global market share. Their saliva-based rapid diagnostics include more than 15 approved devices. In 2023, Abbott distributed over 22 million saliva kits for infectious diseases globally.

By Application

• Forensics: Forensic applications represent 21% of total market usage. Over 25 million forensic samples were collected using saliva kits in 2023. In criminal justice systems across North America and Europe, saliva accounted for 70% of DNA profiling evidence.
• Dentistry: Dentistry applications hold a 9% share. In 2023, over 15 million saliva-based diagnostic tests were performed globally for periodontal disease, oral cancer, and microbial analysis.
• Diagnostic and Pathology Laboratories: Diagnostic labs account for 22% of market share. More than 85 million diagnostic tests in 2023 used saliva as a biological sample, covering infectious diseases, hormone testing, and genetic screening.
• Research Institutes: Research institutions make up 10% of the market. Over 50,000 academic research projects in 2023 employed saliva kits for biomarker identification, neuroscience, and stress physiology.

Saliva Collection Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America represents the largest regional market, with a 41% global share in 2023. The region processed over 120 million saliva samples in healthcare and research. The U.S. dominates with over 42% of worldwide consumption. More than 1,500 clinical laboratories in the U.S. employ saliva diagnostics, while Canada contributes around 5% of the region’s usage with heavy reliance on academic research. Nearly 60 FDA-cleared saliva-based diagnostic kits are in use in the United States, ensuring regulatory trust and clinical acceptance. Forensics in North America heavily utilizes saliva, with 18 million forensic samples collected in 2023. Furthermore, more than 400 ongoing clinical trials in North America incorporate saliva kits for oncology, pharmacogenomics, and metabolic diseases. Growing demand for direct-to-consumer testing, which sold 20 million saliva kits in the U.S. in 2023, also contributes to adoption.

Europe

Europe holds around 28% of the global saliva collection device market. In 2023, the region collected over 85 million saliva samples, with Germany, the UK, and France accounting for more than 60% of total European usage. Over 300 approved diagnostic assays employ saliva-based methods within the region. Forensics is particularly strong in Europe, with saliva contributing to 65% of forensic DNA evidence collected. In addition, more than 25% of European universities incorporated saliva-based biomarker studies in 2023. Pharmaceutical companies in Europe also play a crucial role, with over 700 clinical studies conducted in 2023 using saliva as the primary sample. In dentistry, over 5 million saliva diagnostic tests were carried out for oral cancer and microbial screening. Europe also shows strong adoption of non-invasive testing in pediatrics, with 18% of diagnostic tests for children using saliva.

Asia-Pacific

Asia-Pacific holds approximately 22% of the saliva collection devices market in 2023. The region collected more than 70 million saliva samples. China accounts for nearly 40% of the regional usage, followed by Japan at 25% and India at 15%. The rise of genetic testing kits has fueled consumer demand, with 12 million direct-to-consumer saliva kits sold in China in 2023 alone. Pharma adoption is also rising, with over 500 clinical studies in India and Japan employing saliva samples. Forensic applications have expanded rapidly, with 10 million forensic samples processed using saliva kits in 2023 across Asia. Additionally, research institutions in South Korea and Australia are leading saliva-based cancer biomarker discovery, accounting for 12% of regional usage. Public health agencies in Asia have approved more than 40 saliva-based diagnostic assays for infectious diseases, reflecting strong regulatory support.

Middle East & Africa

The Middle East & Africa region accounts for 9% of the saliva collection device market. In 2023, the region processed approximately 30 million saliva samples. South Africa is the leading country, contributing nearly 35% of regional demand, followed by Saudi Arabia at 28% and the UAE at 15%. Forensic adoption is particularly significant, as saliva evidence accounts for 72% of DNA profiling across major legal systems in the region. Healthcare expansion is also driving demand, with over 50 hospitals in Saudi Arabia integrating saliva diagnostics in infectious disease testing. In South Africa, over 5 million saliva-based HIV tests were conducted in 2023

List of Top Saliva Collection Devices Companies

• OraSure Technologies
• Neogen Corporation
• Isohelix
• Diametra
• AboGen, Inc
• Quest Diagnostics
• Spectrum Solutions
• Oasis Diagnostics
• Abbott Laboratories (Alere)

Top Two Companies with Highest Market Share

• OraSure Technologies – Held 19% of global share in 2023 with over 25 million saliva kits distributed annually.
• Abbott Laboratories (Alere) – Accounted for 12% global share, distributing more than 22 million saliva-based diagnostic kits in 2023.

Investment Analysis and Opportunities

The saliva collection devices market presents strong investment opportunities, driven by rising adoption across pharmaceuticals, forensics, and direct-to-consumer testing. In 2023, over 450 clinical trials integrated saliva kits, creating demand for advanced stabilizing technologies. Investors are focusing on innovations in sample preservation, as 29% of patents filed in 2024 related to long-term stabilization. Venture capital funding for saliva-based diagnostic startups surpassed $800 million globally in 2023, highlighting strong investor confidence.

Pharmaceutical collaborations are another area of opportunity, as more than 120 pharma companies partnered with saliva device manufacturers for genetic and biomarker studies in 2023. Direct-to-consumer testing companies also sold more than 20 million saliva kits in the U.S. alone in 2023, expanding investment potential. In forensic sciences, 25 million samples globally used saliva-based kits, with rising government funding for DNA profiling programs. Emerging markets in Asia-Pacific and Africa, with increasing healthcare budgets and adoption of non-invasive diagnostics, also present untapped opportunities. Investments in AI-integrated saliva testing platforms are expected to expand, as nearly 18% of saliva device companies launched AI-based analysis tools in 2024.

New Product Development

New product development is reshaping the saliva collection devices market. In 2023, Spectrum Solutions launched advanced saliva stabilizers capable of preserving RNA for 7 days at room temperature, addressing degradation challenges. Abbott introduced a rapid saliva-based influenza test, which delivered results within 15 minutes and gained clearance across multiple markets. OraSure Technologies launched an upgraded oral fluid collection kit that enabled higher accuracy in drug testing, with over 95% detection efficiency.

Five Recent Developments

• In 2023, Spectrum Solutions launched an RNA stabilization kit preserving samples for 7 days.
• Abbott released a saliva-based influenza test in 2024, processing results in 15 minutes.
• OraSure introduced upgraded drug testing kits in 2024 with 95% accuracy rates.
• Oasis Diagnostics unveiled cancer biomarker kits in 2024 for oncology studies.
• In 2025, Neogen launched saliva-based veterinary diagnostic kits with over 2 million distributed.

Report Coverage of Saliva Collection Devices Market

The Saliva Collection Devices Market Report provides in-depth analysis of market size, market share, market trends, and market outlook across different regions. The report covers more than 50 key manufacturers, with detailed profiling of leading players such as OraSure Technologies, Abbott Laboratories, Quest Diagnostics, Spectrum Solutions, and others. It evaluates the market segmentation by type and application, offering comprehensive insights into adoption patterns across pharma and biotech companies, forensic applications, dentistry, diagnostic laboratories, and research institutes.

Saliva Collection Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1914.77 Million in 2026
Market Size Value By	USD 3225.51 Million by 2035
Growth Rate	CAGR of 5.97% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : OraSure Technologies Neogen Corporation Isohelix Diametra AboGen Inc Quest Diagnostics Spectrum Solutions Oasis Diagnostics Abbott Laboratories (Alere) By Application : Pharma and Biotech Companies Forensics Dentistry Diagnostic and Pathology Laboratories Research Institutes
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample